Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,479 | 267 | 99.6% |
| Education | $12.36 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $917.99 | 96 | $0 (2024) |
| ABBVIE INC. | $521.10 | 43 | $0 (2024) |
| Lilly USA, LLC | $251.06 | 19 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $210.10 | 14 | $0 (2024) |
| Amgen Inc. | $192.02 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $156.52 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $104.02 | 7 | $0 (2024) |
| PFIZER INC. | $100.11 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $81.46 | 5 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $81.46 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $994.94 | 65 | Novo Nordisk Inc ($183.58) |
| 2023 | $967.52 | 66 | Novo Nordisk Inc ($261.36) |
| 2022 | $712.47 | 63 | Novo Nordisk Inc ($257.10) |
| 2021 | $816.39 | 74 | Novo Nordisk Inc ($215.95) |
All Payment Transactions
268 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: DIABETES | ||||||
| 11/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $9.40 | General |
| 11/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Cardio-renal | ||||||
| 11/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.74 | General |
| 10/27/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $1.16 | General |
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: Obesity | ||||||
| 10/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Inflammation | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $10.94 | General |
| 09/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Inflammation | ||||||
| 08/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 243 | 319 | $55,339 | $19,533 |
| 2022 | 9 | 341 | 408 | $64,124 | $19,988 |
| 2021 | 9 | 331 | 407 | $54,594 | $18,518 |
| 2020 | 7 | 200 | 231 | $28,759 | $7,924 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 162 | $31,752 | $11,271 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 89 | $11,748 | $4,503 | 38.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 35 | 35 | $10,850 | $3,392 | 31.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 14 | 16 | $564.00 | $230.02 | 40.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 16 | 17 | $425.00 | $137.82 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 122 | 164 | $32,144 | $9,614 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 114 | $15,048 | $5,035 | 33.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 42 | 42 | $13,020 | $4,407 | 33.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $726.00 | $298.83 | 41.2% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 21 | 22 | $860.00 | $215.79 | 25.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 12 | 12 | $564.00 | $180.39 | 32.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 11 | 12 | $672.00 | $163.48 | 24.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 18 | 19 | $418.00 | $37.93 | 9.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $672.00 | $36.41 | 5.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 130 | 176 | $34,496 | $12,041 | 34.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 73 | 87 | $11,484 | $4,200 | 36.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 11 | 11 | $3,410 | $997.65 | 29.3% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 29 | 32 | $1,128 | $426.14 | 37.8% |
| 87880 | Strep test by immunoassay for streptococcus | Office | 2021 | 15 | 15 | $840.00 | $247.95 | 29.5% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 27 | 31 | $775.00 | $231.82 | 29.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 13 | $1,027 | $180.35 | 17.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 15 | $840.00 | $132.58 | 15.8% |
| 81003 | Automated urinalysis test | Office | 2021 | 19 | 27 | $594.00 | $60.75 | 10.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 78 | 92 | $18,032 | $4,735 | 26.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 61 | $8,052 | $2,480 | 30.8% |
About Haley Brewster, APRN
Haley Brewster, APRN is a Family healthcare provider based in Bowling Green, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2015. The National Provider Identifier (NPI) number assigned to this provider is 1750758306.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Haley Brewster, APRN has received a total of $3,491 in payments from pharmaceutical and medical device companies, with $994.94 received in 2024. These payments were reported across 268 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,479).
As a Medicare-enrolled provider, Brewster has provided services to 1,115 Medicare beneficiaries, totaling 1,365 services with total Medicare billing of $65,964. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Bowling Green, KY
- Active Since 08/31/2015
- Last Updated 01/26/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1750758306
Products in Payments
- Ozempic (Drug) $259.16
- Wegovy (Drug) $216.29
- UBRELVY (Drug) $214.93
- Kerendia (Drug) $210.10
- QULIPTA (Drug) $182.14
- Saxenda (Drug) $166.78
- TRINTELLIX (Drug) $156.52
- Otezla (Drug) $117.81
- MOUNJARO (Drug) $115.60
- Rybelsus (Drug) $112.33
- JARDIANCE (Drug) $108.21
- REXULTI (Drug) $100.78
- VRAYLAR (Drug) $96.44
- EMGALITY (Drug) $79.84
- Cologuard Collection Kit (Device) $69.65
- NURTEC ODT (Drug) $65.92
- Linzess (Drug) $61.59
- Aimovig (Biological) $57.57
- Azstarys (Drug) $57.06
- TZIELD (Biological) $45.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Bowling Green
Carrie Parrish Nyekan, Aprn, APRN
Family — Payments: $51,758
Ms. Joy Cornelius, Aprn, Pmhnp, APRN, PMHNP
Family — Payments: $19,769
Jeannette Dabit, Aprn, APRN
Family — Payments: $17,565
Colleen Barry, Fnp-C, FNP-C
Family — Payments: $16,695
Mrs. Ashley Towe, Aprn, APRN
Family — Payments: $11,892
Jacqueline Erbse, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $11,734